Robert A Dean

Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease.

Walter J Koroshetz, Max Kuhn, Madhav Thambisetty, 2012, Archives of neurology.

Development, validation, and implementation of a multiplex immunoassay for the simultaneous determination of five cytokines in human serum.

Viswanath Devanarayan, Ronald R Bowsher, Wendell C. Smith, 2005, Journal of pharmaceutical and biomedical analysis.

A novel Aβ isoform pattern in CSF reflects γ-secretase inhibition in Alzheimer disease

Henrik Zetterberg, Kaj Blennow, Ulf Andreasson, 2010, Alzheimer's Research & Therapy.

Development of a novel radioimmunoassay to detect autoantibodies to amyloid beta peptides in the presence of a cross-reactive therapeutic antibody.

Ronald R Bowsher, R. Dean, R. Bowsher, 2011, Journal of pharmaceutical and biomedical analysis.

Robust Central Reduction of Amyloid-β in Humans with an Orally Available, Non-Peptidic β-Secretase Inhibitor

James E Audia, R. Dean, T. Lindstrom, 2011, The Journal of Neuroscience.

Enriching amnestic mild cognitive impairment populations for clinical trials: optimal combination of biomarkers to predict conversion to dementia.

Adam J Schwarz, Peng Yu, E. Siemers, 2012, Journal of Alzheimer's disease : JAD.